We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Database for Acute Myeloblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00538278
Recruitment Status : Active, not recruiting
First Posted : October 2, 2007
Last Update Posted : December 13, 2011
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Prospective Database for Acute Myeloblastic Leukemia

Condition or disease Intervention/treatment
Leukemia, Myeloblastic, Acute Other: Database

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2000 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Study Start Date : October 2007
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020


Arms and Interventions

Intervention Details:
    Other: Database
    database
    Other Name: Registry

Outcome Measures

Primary Outcome Measures :
  1. safety and efficacy [ Time Frame: 10 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with AML
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00538278


Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: Naeem Chaudhri, MD King Faisal Specialist Hospital & Research Centre
More Information

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT00538278     History of Changes
Other Study ID Numbers: RAC #2051-057
First Posted: October 2, 2007    Key Record Dates
Last Update Posted: December 13, 2011
Last Verified: December 2011

Keywords provided by King Faisal Specialist Hospital & Research Center:
AML

Additional relevant MeSH terms:
Leukemia
Leukemia, Myeloid, Acute
Neoplasms by Histologic Type
Neoplasms
Leukemia, Myeloid